| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.18 | 9e-07 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-06 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.19 | 6e-05 |